A Study of Comparing Huachansu Plus Thoracic RT Versus RT Alone For ESCC
Status:
Active, not recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
This primary objective of the trial is to study whether the local control of Huachansu plus
thoracic radiotherapy is better compared to thoracic radiotherapy alone for patients with
esophageal squamous cell carcinoma. It's a phase II study, 134 patients are expected to be
recruited into the trial.